Varicose Vein Treatment Market by Procedure (Injection Sclerotherapy, Endovenous Ablation, Surgical Ligation and Stripping), Product (sclerotherapy injection, Ablation devices and others) and End User (Hospitals, Clinics, and Ambulatory centers): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
- Published Date: 2020-10-18
- Report ID: 3404
- Pages: 175
-
Format:
varicose vein treatment market overview:
The global varicose vein treatment market was valued at $376.64 million in 2017, and is expected to reach $589.06 million by 2025, registering a CAGR of 5.7% from 2018 to 2025. Varicose veins are abnormal, dilated blood vessels caused by weakening of the vessels walls. These veins appear to be swollen, twisted, cluster of blue or purple veins under the skin. Varicose vein disorder affects millions of people all around the world Symptoms usually appear at the age of 40 and generally appear in the legs. Varicose vein is harmful to health if they lead to venous stasis ulcers, phlebitis, thrombosis, venous hemorrhage, or fungal and bacterial infections. According to the American Society of Vascular surgery, at least 20 to 25 million Americans are suffering from varicose vein, among them 17% are men and 33% are women.
Considerable rise in prevalence of varicose vein problem, surge in geriatric population, advanced varicose vein treatment devices, engagement in occupation that increases the prevalence of varicose vein treatment and technological advancements globally, boost the growth of the market. Whereas, increase in level of awareness as well as development in the emerging markets create numerous opportunities in the varicose vein treatment market.
The global varicose vein treatment market is segmented based on procedure, product, end user, and region. Based on procedure, the market is endovenous ablation, injection sclerotherapy, surgical ligation/stripping. Based on product the market is segmented into ablation devices, sclerotherapy injection and others. Ablation devices is further divided into radiofrequency ablation devices, laser ablation devices and others. Based on end user, the market is divided into hospital, clinics, and ambulatory centers. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea and rest of Asia-Pacific) and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Key Benefits for varicose vein treatment market:
The study presents an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
varicose vein treatment Key Market Segments:
By Procedure
Injection Sclerotherapy
Endovenous Ablation
Surgical Ligation/Stripping
By Product
Sclerotherapy injection
Ablation Devices
Radiofrequency Ablation Devices
Laser Ablation Devices
Others
Others
By End User
Hospitals
Clinics
Ambulatory centers
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Alma Lasers Ltd
Angiodynamics, Inc
Biolitec AG
BTG PLC
Energist Ltd
Medtronic
Lumenis
Sciton Inc
Syneron
WONTECH Co., Ltd.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
Teleflex
The Vein Company
F care Systems
Miravas
SharpLight Technologies
Chapter: 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key Market Segments
1.3.1. List of key players profiled in the report:
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Chapter: 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
Chapter: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. key findings
3.2.1. Top investment pockets
3.2.2. Top player positioning
3.3. Market dynamics
3.3.1. Drivers
3.3.1.1. Increasing geriatric population
3.3.1.2. Advanced varicose vein treatment devices
3.3.1.3. Engagement in occupation that increases the prevalence of varicose vein treatment
3.3.1.4. Technological advancement
3.3.2. Restraints
3.3.2.1. Risk factors associated with the treatment devices and less experienced healthcare professionals
3.3.3. Opportunities
3.3.3.1. Increase in level of awareness
3.3.3.2. Untapped markets in emerging markets
3.3.4. Impact analysis
Chapter: 4: VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE
4.1. Overview
4.1.1. Market size and forecast
4.2. Endovenous Ablation
4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Injection Sclerotherapy
4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Surgical Ligation/Stripping
4.4.1. Key trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
Chapter: 5: VARICOSE VEIN TREATMENT MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Ablation Devices
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.2.2.1. Radiofrequency Ablation Devices
5.2.2.2. Laser ablation devices
5.2.2.3. Others
5.2.3. Sclerotherapy Injection
5.2.4. Market size and forecast
5.2.5. Market analysis, by country
5.2.6. Others
5.2.7. Market size and forecast
5.2.8. Market analysis, by country
Chapter: 6: VARICOSE VEIN TREATMENT MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Ambulatory Centers
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Clinics
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
Chapter: 7: VARICOSE VEIN TREATMENT MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. North America market size & forecast, by country
7.2.2.1. U.S. market size & forecast, by procedure
7.2.2.2. U.S. market size & forecast, by product
7.2.2.3. U.S. market size & forecast, by end user
7.2.2.4. Canada market size & forecast, by procedure
7.2.2.5. Canada market size & forecast, by product
7.2.2.6. Canada market size & forecast, by end user
7.2.2.7. Mexico market size & forecast, by procedure
7.2.2.8. Mexico market size & forecast, by Product
7.2.2.9. Mexico market size & forecast, by end user
7.2.3. North America market size & forecast, by procedure
7.2.4. North America market size & forecast, by product
7.2.5. North America market size & forecast, by end user
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Europe market size & forecast for varicose vein treatment market, by country
7.3.2.1. Germany market size & forecast, by procedure
7.3.2.2. Germany market size & forecast, by product
7.3.2.3. Germany market size & forecast, by end user
7.3.2.4. France market size & forecast, by Procedure
7.3.2.5. France market size & forecast, by product
7.3.2.6. France market size & forecast, by end user
7.3.2.7. UK market size & forecast, by procedure
7.3.2.8. UK market size & forecast, by product
7.3.2.9. UK market size & forecast, by end user
7.3.2.10. Italy market size & forecast, by procedure
7.3.2.11. Italy market size & forecast, by product
7.3.2.12. Italy market size & forecast, by end user
7.3.2.13. Spain market size & forecast, by procedure
7.3.2.14. Spain market size & forecast, by product
7.3.2.15. Spain market size & forecast, by end user
7.3.2.16. Rest of Europe market size & forecast, by procedure
7.3.2.17. Rest of Europe market size & forecast, by product
7.3.2.18. Rest of Europe market size & forecast, by end user
7.3.3. Europe market size & forecast, by procedure
7.3.4. Europe market size & forecast, by product
7.3.5. Europe market size & forecast, by end user
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Asia-Pacific market size & forecast, by country
7.4.2.1. Japan market size & forecast, by procedure
7.4.2.2. Japan market size & forecast, by product
7.4.2.3. Japan market size & forecast, by end user
7.4.2.4. China market size & forecast, by procedure
7.4.2.5. China market size & forecast, by product
7.4.2.6. China market size & forecast, by end user
7.4.2.7. India market size & forecast, by procedure
7.4.2.8. India market size & forecast, by product
7.4.2.9. India market size & forecast, by end user
7.4.2.10. Australia market size & forecast, by procedure
7.4.2.11. Australia market size & forecast, by product
7.4.2.12. Australia market size & forecast, by end user
7.4.2.13. South Korea market size & forecast, by procedure
7.4.2.14. South Korea market size & forecast, by product
7.4.2.15. South Korea market size & forecast, by end user
7.4.2.16. Rest of Asia-Pacific market size & forecast, by procedure
7.4.2.17. Rest of Asia-Pacific market size & forecast, by product
7.4.2.18. Rest of Asia-Pacific market size & forecast, by end user
7.4.3. Asia-Pacific market size & forecast, by procedure
7.4.4. Asia-Pacific market size & forecast, by product
7.4.5. Asia-Pacific market size & forecast, by end user
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. LAMEA market size & forecast, by country
7.5.2.1. Brazil market size & forecast, by procedure
7.5.2.2. Brazil market size & forecast, by product
7.5.2.3. Brazil market size & forecast, by end user
7.5.2.4. South Africa market size & forecast, by procedure
7.5.2.5. South Africa market size & forecast, by product
7.5.2.6. South Africa market size & forecast, by end user
7.5.2.7. Saudi Arabia market size & forecast, by procedure
7.5.2.8. Saudi Arabia market size & forecast, by product
7.5.2.9. Saudi Arabia market size & forecast, by end user
7.5.2.10. Rest of LAMEA market size & forecast, by procedure
7.5.2.11. Rest of LAMEA market size & forecast, by product
7.5.2.12. Rest of LAMEA market size & forecast, by end user
7.5.3. LAMEA market size & forecast, by procedure
7.5.4. LAMEA market size & forecast, by product
7.5.5. LAMEA market size & forecast, by end user
Chapter: 8: COMPANY PROFILES
8.1. Angiodynamics Inc
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product Portfolio
8.1.5. Business performance
8.2. Alma Lasers
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Key strategic moves and developments
8.3. biolitec AG Untere Viaduktgasse
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.4. BTG International Ltd
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product Portfolio
8.4.5. Business performance
8.5. Energist Ltd
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Product Portfolio
8.6. Lumenis
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product Portfolio
8.7. Medtronic
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.8. Sciton Inc
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product Portfolio
8.9. Syneron Medical Ltd
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product Portfolio
8.9.5. Key strategic moves and developments
8.10. WON TECH Co., Ltd
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product Portfolio
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
